New Hope for Rapid-Acting Depression Treatment

October 24, 2024
A new study, funded in part by the National Institute of Mental Health, showed that a new medication derived from ketamine is safe and acceptable for use in humans, setting the stage for clinical trials testing it for hard-to-treat mental disorders like severe depression.
Published On: October 24, 2024Categories: Uncategorized44 wordsViews: 1083
Go to Top